Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.32093 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.30691 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.24749 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.2824 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.26393 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.31197 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.30439 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.28902 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.29074 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.30309 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.28711 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.29429 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.42015 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.15076 | 68 |